Biotech & Life Sciences investors in New York
50 funds · Updated
Gatsbie lists 50 Biotech & Life Sciences investors headquartered in New York (as of 2026-11-18).
30 name biotech & life sciences in their investment focus; 20 invest across sectors.
The most common stages are Seed (35), Series A (28) and Pre-Seed (23); the most common kinds of capital are Venture equity (46), Growth equity (18) and Debt (13).
Which Biotech & Life Sciences investors are based in New York?
Gatsbie lists 50 Biotech & Life Sciences investors headquartered in New York (as of 2026-11-18). They include HOF Capital, Aisling Capital, The Venture Collective, Vedanta Capital Lp, Endeavor Catalyst and Third Kind Venture Capital.
Which family offices invest in Biotech & Life Sciences in New York?
9 of the 50 Biotech & Life Sciences investors on Gatsbie are family offices, including Global Realty Capital LLC, Aeterna Capital Partners, MSD Capital, BELFER MANAGEMENT LLC and QUADRANT MANAGEMENT.
Upload your deck to see which of these fit your startup, with a written reason for each.
20 of 50 funds
Most active first: deals in the last 24 months, then portfolio companies on record.
| # | Fund | HQ | Stages | Partner emails |
|---|---|---|---|---|
| 1 | HOF Capital | New York | Pre-Seed–Series B | 16 |
| 2 | Aisling Capital | New York | Seed–Series C+ | 6 |
| 3 | The Venture Collective | New York | Pre-Seed–Series A | 5 |
| 4 | Vedanta Capital Lp | New York | Growth | 8 |
| 5 | Endeavor Catalyst | New York | Series C+ | 30 |
| 6 | Third Kind Venture Capital | New York | Pre-Seed–Series B | 2 |
| 7 | OrbiMed | New York | Seed, Growth | 53 |
| 8 | Exsight Ventures | New York | Pre-Seed–Series B | 5 |
| 9 | Blackstone | New York | Pre-Seed–Series A, Growth | 22 |
| 10 | Compound | New York | Seed | 4 |
| 11 | Deerfield Management | New York | Pre-Seed–Series B | 29 |
| 12 | Emerald | New York | Pre-Seed–Series A | 6 |
| 13 | New Enterprise Associates, Inc. (NEA) | New York | Pre-Seed–Series B | 38 |
| 14 | New Science Ventures | New York | Series C+ | 4 |
| 15 | Radius Ventures | New York | – | 2 |
| 16 | NGN Capital | New York | Pre-Seed–Series B | 3 |
| 17 | Aperture Venture Partners | New York | Seed–Series C+ | 4 |
| 18 | Windham Venture Partners | New York | Pre-Seed–Series B | 5 |
| 19 | Bill & Melinda Gates Foundation | New York | Pre-Seed–Series B | 10 |
| 20 | Digitalis Ventures | New York | Pre-Seed–Series B | 13 |
See more Biotech & Life Sciences investors in Investor Discovery
Biotech & Life Sciences combined with another sector
Biotech & Life Sciences investors elsewhere
- Biotech & Life Sciences in North America 374
- Biotech & Life Sciences in the United States 364
- Biotech & Life Sciences in Europe 197
- Biotech & Life Sciences in the San Francisco Bay Area 92
- Biotech & Life Sciences in the United Kingdom 72
- Biotech & Life Sciences in London 57
- Biotech & Life Sciences in Asia-Pacific 56
- Biotech & Life Sciences in Germany 30
- Biotech & Life Sciences in the Middle East & North Africa 30
- Biotech & Life Sciences in India 22
- Biotech & Life Sciences in Boston 21
- Biotech & Life Sciences in Switzerland 20
Other sectors in New York
- Fintech in New York 302
- AI in New York 295
- Healthcare & MedTech in New York 278
- Consumer Apps in New York 267
- Enterprise Software in New York 158
- Developer Tools in New York 153
- AgTech & FoodTech in New York 138
- Hardware & IoT in New York 127
- CleanTech & Climate in New York 122
- Logistics & Supply Chain in New York 117
- E-commerce & Marketplace in New York 113
- PropTech in New York 113
Counted by where each fund is headquartered, from public sources, as of 2026-11-18. Funds that invest across sectors are included, as in Investor Discovery.
